The civic record
Read. Follow. Verify.Idaho House Bill 531 authorizes schools to maintain stock epinephrine delivery systems and provides civil liability protections
Last action · March 17, 2026: Reported Signed by Governor on March 16, 2026 Session Law Chapter 23 Effective: 07/01/2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Idaho House Bill 531 permits public and nonpublic schools to maintain a stock supply of epinephrine delivery systems for emergency administration to individuals experiencing . The measure allows trained school nurses and designated personnel to administer epinephrine even if the student lacks an individual prescription, and it establishes civil liability protections for schools and healthcare providers acting reasonably under the circumstances. The law takes effect July 1, 2026.
Schools may now acquire and keep emergency epinephrine on-site without individual student prescriptions, altering emergency medical response protocols and liability standards for school districts and healthcare professionals.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
school districts
School districts must adopt self-administration policies, may choose to maintain stock epinephrine supplies, and must establish incident reporting and training standards.
students
Students are permitted to possess and self-administer prescribed inhalers and epinephrine auto-injectors at all times and can receive stock epinephrine during an emergency.
school nurses and designated school personnel
School staff may be authorized to provide and administer epinephrine delivery systems to students based on individual prescriptions or during emergency anaphylaxis events.
prescribing healthcare providers and pharmacists
Physicians, advanced practice registered nurses, physician assistants, and pharmacists are authorized to prescribe and dispense epinephrine in the name of a school and receive specific civil liability protections.
Key Facts
- The board of trustees of each school district and charter district must adopt a policy permitting pupil self-administration of prescribed metered-dose inhalers and epinephrine auto-injector delivery systems.
- Schools are authorized to maintain a stock supply of epinephrine delivery systems for emergency use.
- Physicians, advanced practice registered nurses, and physician assistants may prescribe epinephrine auto-injector delivery systems in the name of a school.
- Licensed pharmacists and physicians may dispense epinephrine auto-injectors pursuant to a school prescription.
Show all 10 facts
- School nurses and designated personnel may administer an epinephrine delivery system to any student or individual on school premises believed to be experiencing anaphylaxis, regardless of whether a prescription exists.
- Schools may enter into arrangements with manufacturers or third-party suppliers to obtain epinephrine delivery systems at fair market price, reduced price, or free.
- Schools participating in the epinephrine supply program must require each school maintaining stock to report every severe allergic reaction or epinephrine administration incident.
- Participating schools must establish detailed online or in-person training program standards covering symptom recognition, storage, administration, disposal, and emergency follow-up.
- Prescribing healthcare providers, pharmacists, schools, and their employees or agents are granted civil liability protections for actions taken reasonably under the circumstances, excluding gross negligence or reckless behavior.
- The act declares an emergency and takes effect on July 1, 2026.
Frequently Asked Questions
Can school staff administer epinephrine to a student who does not have a personal prescription?
What training is required for school personnel who administer epinephrine?
Are schools and medical providers protected from lawsuits under this law?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
18 actions- Mar 17, 2026EnrolledReported Signed by Governor on March 16, 2026 Session Law Chapter 23 Effective: 07/01/2026
- Mar 11, 2026Delivered to Governor at 3:53 p.m. on March 10, 2026
- Mar 10, 2026Returned Signed by the President; Ordered Transmitted to Governor
- Mar 10, 2026Signed by President; returned to House
- Mar 10, 2026Received from the House enrolled/signed by Speaker
- Mar 9, 2026Reported Enrolled; Signed by Speaker; Transmitted to Senate
Show 12 earlier actions
- Mar 9, 2026FloorReturned from Senate Passed; to JRA for Enrolling
- Mar 6, 2026FloorRead third time in full – PASSED - 31-0-4 AYES – Adams, Anthon, Bernt, Bjerke(Bjerke), Blaylock, Burtenshaw, Carlson, Cook, Foreman, Grow, Guthrie, Harris, Hart, Keyser, Keyser(Galloway), Kohl, Lakey, Lenney, Nichols, Okuniewicz, Ricks, Ruchti, Semmelroth, Shippy, Taylor, Toews, VanOrden, Ward-Engelking, Wintrow, Zito, Zuiderveld NAYS – None Absent and excused – Den Hartog, Lent, Rabe, Woodward Floor Sponsor - Blaylock Title apvd - to House
- Feb 20, 2026Read second time; filed for Third Reading
- Feb 19, 2026Reported out of Committee with Do Pass Recommendation; Filed for second reading
- Feb 10, 2026IntroducedIntroduced, read first time; referred to: Education
- Feb 10, 2026FloorReceived from the House passed; filed for first reading
- Feb 9, 2026FloorRead Third Time in Full – PASSED - 69-0-1 AYES – Alfieri, Barbieri, Beiswenger, Berch, Bingham, Boyle, Bruce, Burgoyne, Cannon, Cayler, Cheatum, Church, Cornilles, Crane(12), Crane(13), Dygert, Egbert, Ehardt, Ehlers, Erickson, Fuhriman, Furniss, Galaviz, Gannon, Garner, Green, Hall(Stone), Handy, Harris, Hawkins, Haws, Healey, Hill, Holtzclaw, Hostetler, Leavitt, Manwaring, Marmon, Mathias, McCann, Mendive, Mickelsen, Miller, Mitchell, Monks, Nelsen, Palmer, Petzke, Pickett, Pohanka, Price, Rasor, Raybould, Raymond, Redman, Rubel, Sauter, Scott, Shepherd, Shirts, Skaug, Tanner(13), Tanner(14), Thompson, Vander Woude, Veile, Weber, Wheeler, Mr. Speaker NAYS – None Absent – Wisniewski Floor Sponsor - Wheeler Title apvd - to Senate
- Feb 6, 2026U.C. to hold place on third reading calendar until Monday, February 9, 2026
- Feb 5, 2026Read second time; Filed for Third Reading
- Feb 4, 2026Reported out of Committee with Do Pass Recommendation, Filed for Second Reading
- Jan 27, 2026CommitteeReported Printed and Referred to Health & Welfare
- Jan 26, 2026IntroducedIntroduced, read first time, referred to JRA for Printing
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Connected Entities
Sources
legislature.idaho.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
